CorMedix (CRMD) Amortization - Intangibles (2024 - 2025)
CorMedix (CRMD) reported Amortization - Intangibles of $10.1 million for Q4 2025, up 19360.22% on a YoY basis from N/an in Q4 2024, and up 179.44% sequentially from $3.6 million in Q3 2025.
CorMedix (CRMD) Amortization - Intangibles (2024 - 2025) Analysis & Trends
CorMedix (CRMD) has 2 years of Amortization - Intangibles data on file, last reported at $10.1 million in Q4 2025.
- For the quarter ending Q4 2025, Amortization - Intangibles rose 19360.22% year-over-year to $10.1 million; the trailing twelve-month figure through Dec 2025 stood at $13.9 million (changed N/A YoY), and the FY2025 full-year result was $13.9 million, up 8792.31% from the prior year.
- Amortization - Intangibles grew to $10.1 million in Q4 2025, from $3.6 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $10.1 million in Q4 2025 to a low of $51948.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.14 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Dec 31, 2024 | 52,104.00 |
| Sep 30, 2024 | 51,948.00 |